Charts N2Tech Co.,Ltd

Stocks

End-of-day quote Korea S.E. 2026-10-01			5-day change	1st Jan Change
1,269.00 ^KRW	+5.57%		+5.05%	-23.09%

09-22	Aprogen Medicines Inc. announced that it has received KRW 20 billion in funding from N2Tech Co.,Ltd, APTOCROM Inc., Aprogen Pharma Inc.	CI
09-20	N2Tech Co.,Ltd announced that it has received KRW 10 billion in funding from Ocean In W Co.,Ltd.	CI

Korea S.E.KRW

Markets		Quality
Korea S.E.	A227950	End-of-day quote

ProRealTime Chart